{
    "html_item": {
        "id": 17775573,
        "html_text": "<hr><p><span style=\"font-size: 14px; font-family: Verdana, Geneva, sans-serif; color: rgb(0, 0, 0);\"><strong>To:&nbsp;</strong>andy.taft@panacead.com</span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>From:&nbsp;</strong>karen.norris@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Date:&nbsp;</strong>1 September 2025, 9:51</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Subject:&nbsp;</strong>Thoughts on Krynoxi/Introdisem Acquisition</span></span></span></p><hr><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Morning Andy,</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Hope you&rsquo;ve had a good start to the week!</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">I was wondering if you had any thoughts on the Krynoxi/Introdisem acquisition since our call on Monday? I think everyone on the team can see that it is a good idea on paper - but I&rsquo;m unsure whether we&rsquo;d want the whole of Krynoxi or just Introdisem.&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Anyway, I know you&rsquo;re more of an expert regarding our actual product line, so do let me know whether there are synergies beyond just Permorbus and Introdisem!</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Many thanks,</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Karen</span></span></span></p><p><br></p><hr><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>To:&nbsp;</strong>karen.norris@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>From:</strong> andy.taft@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Date:&nbsp;</strong>1 September 2025, 10:25</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Subject:&nbsp;</strong>RE: Thoughts on Krynoxi/Introdisem Acquisition</span></span></span></p><hr><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Good morning Karen,</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">It&rsquo;s been busy as always - organising a roadshow to keep stoking the interest in Permorbus is a little tricky when the venue managers won&rsquo;t reply!</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Regarding the acquisition - I think it is a great idea! Having Introdisem in our arsenal would present several lucrative opportunities.&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">First, combining Introdisem and Permorbus into one package (i.e. a separate product) would cement Panacead&rsquo;s position as the sole supplier of the &ldquo;gold standard&rdquo; of glioblastoma treatment. Simply put, no other pharmaceutical company offers this kind of one-stop-shop product package so there is a perfect gap in the market for us to fill.</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">And, in response to your last remark, there is no reason why this should be limited to just Permorbus! We have a whole range of medications that could benefit from Introdisem. To begin with, we already supply five other cancer-combating drugs around the world and we have another two in the pipeline. However, I&rsquo;m sure that my R&amp;D team could find uses for Introdisem beyond combating cancer; for example, using Introdisem to administer and target medications for more common diseases, like glaucoma.</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">So, all in all, selling our medications with Introdisem would make our products the (extraordinarily high!) benchmark to beat in the pharmaceuticals market. Admittedly, this would probably increase the cost of such a product as we are essentially bundling two into one, but I&rsquo;m sure, over time, we would benefit from economies of scale.</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Second, if we own the rights to Introdisem, we could also choose to sell it to other pharmaceutical companies. As I mentioned, I think administering drugs with Introdisem will be the gold standard for the next 5-10 years. Hence, if our competitors don&rsquo;t want to lose out on business, they&rsquo;ll need to start using it too! So, if we own Introdisem, we can use it for our own products and/or sell Introdisem to our competitors to turn a profit. I think there will be quite a high demand for it, and if we are the only supplier, that can only benefit us!</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Anyway, apologies for the overly long email but I think there are some great benefits to acquiring Krynoxi/Introdisem!</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Best,</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Andy</span></span></span></p><p><br></p><hr><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>To:&nbsp;</strong>andy.taft@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>From:&nbsp;</strong>karen.norris@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Date:&nbsp;</strong>1 September 2021, 10:32</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Subject:&nbsp;</strong>RE: RE: Thoughts on Krynoxi/Introdisem Acquisition</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Hey Andy,</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Wow - no wonder you made Chief Research Officer so quickly! I don&rsquo;t suppose you&rsquo;ve got something for my bad back&hellip;?</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Anyway, thank you so much for your email - I&rsquo;ll schedule a call with the lawyers soon to discuss some of these points.</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Just as an aside - if we were to go ahead with this transaction - would purchasing the whole of Krynoxi be necessary? Or could we just carve out Introdisem and take that? I know you don&rsquo;t necessarily know the ins and outs of it all, but it would be good to hear if you had a perspective!</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Best,</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Karen</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><hr><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>To:</strong> karen.norris@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>From:&nbsp;</strong>andy.taft@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Date:&nbsp;</strong>1st September 2025, 10:40</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Subject:&nbsp;</strong>RE: RE: RE: Thoughts on Krynoxi/Introdisem Acquisition</span></span></span></p><hr><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Hi Karen,</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Nothing for the back I&rsquo;m afraid - the team and I are more focused on liver right now!</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Truth be told, I don&rsquo;t know too much about acquiring companies and the like. However, in my experience (especially in pharmaceuticals), if you don&rsquo;t buy the whole company (say, you just get a product), you&rsquo;ll usually want to also acquire some of the people who developed it.</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">I only say this because we research, develop and manufacture <em>drugs</em>, whilst Krynoxi make <em>equipment</em>. So, whilst my team and I can work out what Introdisem does, I think we&rsquo;d be hard-pressed to manufacture it and quickly improve upon it on our own, as, at this precise moment, we don&rsquo;t have the experts or the factories.</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">I don&rsquo;t know whether that helps or not - but that&rsquo;s my two cents!</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Best,</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Andy</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><hr><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>To:&nbsp;</strong>andy.taft@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>From:&nbsp;</strong>karen.norris@panacead.com</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Date:</strong> 1 September 2025, 10:32</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\"><strong>Subject:</strong> RE: RE: RE: RE: Thoughts on Krynoxi/Introdisem Acquisition</span></span></span></p><hr><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Hi Andy,</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Okay, that&rsquo;s interesting - I&rsquo;ll have a chat with the lawyers soon.&nbsp;</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Right, I&rsquo;ll leave you to your Wednesday morning!</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Thanks,</span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">&nbsp;</span></span></span></p><p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-family: Verdana,Geneva,sans-serif;\"><span style=\"font-size: 14px;\">Karen</span></span></span></p>"
    }
}